Filing Details

Accession Number:
0001209191-13-005987
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-04 16:27:12
Reporting Period:
2013-02-01
Filing Date:
2013-02-04
Accepted Time:
2013-02-04 16:27:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463321 Susan Mahony Lilly Corporate Center
Indianapolis IN 46285
Svp & Pres., Lilly Oncology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-02-01 10,777 $53.69 34,437 No 4 F Direct
Common Stock Acquisiton 2013-02-01 22,943 $0.00 57,380 No 4 M Direct
Common Stock Disposition 2013-02-01 5,000 $54.28 52,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2013-02-01 22,943 $0.00 22,943 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-01 2013-02-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,498 Indirect 401(k)
Common Stock 1,489 Indirect 401(k) - by husband
Common Stock 6,218 Indirect by husband
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2013.
  2. Reporting person disclaims beneficial ownership of these shares.